Investor mix
7 investors on record; lead investors include Volcanics Venture, ShenZhen GTJA Investment Group, LH Ventures, CDH.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 2 | 29% |
| Bank & private debt | 1 | 14% |
Developer of CAR-T cell therapies for blood cancers and solid tumors
7 investors on record; lead investors include Volcanics Venture, ShenZhen GTJA Investment Group, LH Ventures, CDH.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 2 | 29% |
| Bank & private debt | 1 | 14% |